Quiero saber acerca de...

Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices 12. What are some possible challenges of Federal licensure?
13. How would Federal licensure impact operations and other requirements, such as grant/contract or insurance requirements?
14. What agency or entity should investigate and inspect federally licensed facilities?
15. Comments regarding a Federal licensing scheme versus a Federal accreditation plan.
16. How can considerations for an ORR
Federal licensing, accreditation, and/or monitoring scheme inform additional or aligned guidance and standards for other fulltime child-caring facilities supported by ORR
or HHS?
17. What information should ORR provide to the public on ORR-funded or ORRlicensed shelter facilities?
18. What resources should ORR consider if it develops a Federal licensing, accreditation, and/or monitoring program?
19. Would a Federal licensing or accreditation program need to work differently in different care environments, such as residential childcare institutions, group homes, and child behavioral health facilities?
20. Would you recommend any alternatives to a Federal licensing or accreditation scheme?
21. Any additional topics you wish to provide input on.
The information received will inform the planning for executing a new Federal licensing scheme or accreditation program.
Dated: September 1, 2021.
Cindy Huang, Director, Office of Refugee Resettlement.

Instructions regarding attending this meeting virtually will be posted at least one week prior to the meeting at: http www.hhs.gov/
paccarb.

ADDRESSES:

FR Doc. 202119263 Filed 9121; 4:15 pm BILLING CODE 418445P

FOR FURTHER INFORMATION CONTACT:

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings of the Presidential Advisory Council on Combating AntibioticResistant Bacteria Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.
ACTION: Notice.
AGENCY:

lotter on DSK11XQN23PROD with NOTICES1

VerDate Sep<11>2014

16:55 Sep 02, 2021

Jkt 253001

Jomana Musmar, M.S., Ph.D., Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room L616, Switzer Building, 330 C St. SW, Washington, DC 20024.
Phone: 2027461512; Email: CARB@
hhs.gov.
The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria PACCARB, established by Executive Order 13676, is continued by Section 505 of Public Law 11622, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 PAHPAIA. Activities and duties of the Advisory Council are governed by the provisions of the Federal Advisory Committee Act FACA, Public Law 92463, as amended 5 U.S.C. app., which sets forth standards for the formation and use of federal advisory committees.

SUPPLEMENTARY INFORMATION:

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services HHS is hereby giving notice that two meetings are scheduled to be held for the Presidential Advisory Council on Combating AntibioticResistant Bacteria PACCARB. The meetings will be open to the public via WebEx and teleconference; a preregistered public comment session will be held during both meetings. Preregistration is required for members of the public who wish to attend the meetings via WebEx/teleconference.

SUMMARY:

Individuals who wish to send in their written public comment should send an email to CARB@hhs.gov. Registration information is available on the website http www.hhs.gov/paccarb and must be completed by October 1, 2021 for the October 6, 2021 virtual Public Meeting;
and, by November 29, 2021 for the November 30December 1, 2021 virtual Public Meeting. Additional information about registering for the meeting and providing public comment can be obtained at http www.hhs.gov/paccarb on the Upcoming Meetings page.
DATES: The October meeting is scheduled to be held on October 6, 2021, from 10:00 a.m. to 11:00 a.m. ET
times are tentative and subject to change. The November/December meeting is scheduled to be held on November 30, 2021 from 10:00 a.m. to 3:00 p.m. and December 1, 2021, from 10:00 a.m. to 3:00 p.m. ET times are tentative and subject to change. The confirmed times and agenda items for both meetings will be posted on the website for the PACCARB at http
www.hhs.gov/paccarb when this information becomes available. Preregistration for attending the meeting is strongly suggested and should be completed no later than October 1, 2021
for the October meeting and November 29, 2021 for the November/December meeting.

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

49551

The PACCARB shall advise and provide information and recommendations to the Secretary regarding programs and policies intended to reduce or combat antibioticresistant bacteria that may present a public health threat and improve capabilities to prevent, diagnose, mitigate, or treat such resistance. The PACCARB shall function solely for advisory purposes.
Such advice, information, and recommendations may be related to improving: The effectiveness of antibiotics; research and advanced research on, and the development of, improved and innovative methods for combating or reducing antibiotic resistance, including new treatments, rapid point-of-care diagnostics, alternatives to antibiotics, including alternatives to animal antibiotics, and antimicrobial stewardship activities;
surveillance of antibiotic-resistant bacterial infections, including publicly available and up-to-date information on resistance to antibiotics; education for health care providers and the public with respect to up-to-date information on antibiotic resistance and ways to reduce or combat such resistance to antibiotics related to humans and animals; methods to prevent or reduce the transmission of antibiotic-resistant bacterial infections; including stewardship programs; and coordination with respect to international efforts in order to inform and advance the United States capabilities to combat antibiotic resistance.
The October 6, 2021 public meeting will be held virtually and is dedicated to deliberation and vote of the letter with recommendations from the Immediate Action Subcommittee of the Advisory Council. The meeting agenda will be posted on the PACCARB website at http www.hhs.gov/paccarb when it has been finalized. All agenda items are tentative and subject to change.
The November 31, 2021 and December 1, 2021 public meeting will be held virtually and will be dedicated to addressing the current situation regarding antimicrobial resistance as well as to a presentation from the National Academies of Sciences, Engineering, and Medicine on their report, Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States. The meeting agenda will be posted on the PACCARB website at http
www.hhs.gov/paccarb when it has been finalized. All agenda items are tentative and subject to change.
Instructions regarding attending both meetings virtually will be posted one
E:FRFM03SEN1.SGM

03SEN1